跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Glizen 30 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Glizen 30
Approved
STANDARD
Glizen 30
Bal Pharma Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
c37f51a76e83f005
Company
Bal Pharma Ltd.
Type
Standard
Approval Details
Approval Id
c37f51a76e83f005
Drug Approval Philippines Name
Glizen 30
Product Name
Glizen 30
Registration Number
DRP-5769-11
Brand Name
Glizen 30
Generic Name
Gliclazide
Dosage Form
Modified-Release Tablet
Dosage Strength
30 mg
Manufacturer
Bal Pharma Ltd.
Importer
Pharmakon Biotec Inc.
Distributor
Hale Medipoint Corp
Issuance Date
24 June 2024
Expiry Date
13 June 2029
Pharmacologic Category
Oral Hypoglycemic Agent
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
c37f51a76e83f005
Type
Standard
Back to Philippines FDA Approvals